The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The ...
Doctors can administer Ozempic to eligible patients via disposable, single-use injection pens intended for use in the abdomen, thigh or upper arm. According to Novo Nordisk, Ozempic should ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results